<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Morphea (localized scleroderma) in adults: Selection of initial treatment</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Morphea (localized scleroderma) in adults: Selection of initial treatment</h1>
<div class="graphic"><div class="figure"><div class="ttl">Morphea (localized scleroderma) in adults: Selection of initial treatment</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Following achievement of disease control, treatment is typically tapered, as tolerated. Phototherapy is an exception; we typically cease treatment after completion of an appropriate treatment course and resolution of signs of disease activity. Patients should be followed for recurrence of disease activity. Refer to UpToDate topics on the management of morphea in adults for details.</div><div class="graphic_footnotes">UVA1: ultraviolet A1; UVB: ultraviolet B; UVA: ultraviolet A.<br/>* Inactive morphea is unlikely to respond to immunomodulatory therapy or phototherapy. Interventions for inactive morphea are primarily focused on improvement of functional impairment and disfigurement as well as monitoring for recurrence of disease activity.<br/>¶ Examples include facial involvement and tethered or deeply sclerotic lesions that overlie joints.<br/>Δ The goal of multidisciplinary management is to maximize function and minimize further disability.<br/><font class="lozenge">◊</font> The relative efficacy of these interventions is unclear. We primarily use topical corticosteroids. In our experience, lesions that exhibit associated epidermal changes (eg, lichen sclerosis-like features overlying indurated plaques) respond best to topical therapy.<br/>§ Phototherapy options include UVA1, narrowband UVB, and broadband UVA. In general, when UVA1 phototherapy is available, we favor this modality. Due to less depth of penetration of UVB in comparison with UVA1 and broadband UVA, we usually reserve narrowband UVB for patients with lesions that are relatively superficial, exhibiting only mild induration.<br/>¥ We reserve the addition of systemic glucocorticoids for patients with very inflammatory, rapidly progressive morphea (eg, evolution to involve multiple body sites or rapid extension of lesions over multiple joints within less than 6 months).<br/>‡ Intralesional corticosteroid injections should be limited to patients with a small area of involvement in whom the depth of morphea does not extend beyond the subcutaneous tissue.</div><div id="graphicVersion">Graphic 130272 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
